prednylidene (Pred)

Subscribe to Selected New Research on prednylidene

363 relevant articles (18 outcomes, 38 trials/studies) found for this Bio-Agent

Description: RN given refers to (11beta)-isomer

Also Known As:

Pred; 16-methyleneprednisolone; Decortilen; Merck brand of prednylidene

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 59

Experts

1.	Seo, Young Lan: 1 article (10/2007)
2.	Lee, Joon Won: 1 article (10/2007)
3.	Kim, Keon Ha: 1 article (10/2007)
4.	Hwang, Hee Sung: 1 article (10/2007)
5.	Yoon, Dae Young: 1 article (10/2007)
6.	Choi, Chul Soon: 1 article (10/2007)
7.	Chang, Suk Ki: 1 article (10/2007)
8.	Yun, Eun Joo: 1 article (10/2007)
9.	Püspök, A: 1 article (12/2003)
10.	Scheithauer, W: 1 article (12/2003)

Related Diseases

1.	Asthma (Bronchial Asthma) 04/01/2009 - "By combined therapy for one month the asthma symptoms relieved and FEV(1)%pred improved significantly (P < 0.01). " 01/01/2006 - "Twenty patients (12 M, 8 F, mean age 39,6+/-16,3 yrs) with asthma (mean FEV, 81+/-19.5% pred.; mean FEV(1)%VC 69+/-12.3%) participated in the study. " 01/01/2005 - "To this end, we analyzed baseline data of 27 subjects with mild persistent asthma (20F/7M) 19-46 y; FEV1 81-136% pred.; PC20FEV1 (M)<80 micromol/mL) participating in a proof-of-concept study. " 01/01/2001 - "OBJECTIVE: In this study the relationship has been studied between exposure time and potential prognostic factors and FEV1 percent predicted (FEV1-% pred) in workers with potroom asthma, after their transfer from exposure to exposure-free departments. " 12/01/2008 - "Patients aged 18-60 years presenting with acute asthma and FEV1 < 30 % predicted (pred.) were included. " Order ALL the reference details at left...
2.	Chronic Obstructive Pulmonary Disease (COPD) 12/01/2000 - "Among the entire group of first-degree relatives of early-onset COPD probands, univariate analysis demonstrated similar spirometric values and bronchodilator responsiveness in males and females; however, among current or ex-smokers, female first-degree relatives had significantly lower FEV(1)/ FVC (81.4 +/- 17.2% in females versus 87.0 +/- 12.9% in males, p = 0.009) and significantly greater bronchodilator responsiveness (expressed as percentage of baseline FEV(1)) (7.7 +/- 9.4% pred in females versus 4.1 +/- 6.4% pred in males, p = 0.002). " 06/01/2006 - "In the present study, the cardiopulmonary stress of a 12-week exercise training programme in 11 chronic obstructive pulmonary disease (COPD) patients (forced expiratory volume in one second 42+/-12%pred, age 69+/-6 yrs) was measured. " 05/01/2006 - "The effects of training on dynamic hyperinflation in stable chronic obstructive pulmonary disease (COPD) were investigated by using a controlled study of 28 subjects with FEV(1) = 42.5 (8.3 SD)%pred and 20 matched controls [FEV(1) = 44.9 (10.4)%pred]. " 02/01/2004 - "This report describes 39 patients with severe COPD ((mean +/- SE) forced expiratory volume in one second 32 +/- 2% pred, functional residual capacity 195 +/- 6% pred) who participated in a randomised controlled trial of LVRS and who completed incremental exercise tests at 6 months as well as endurance tests (constant power of 25 +/- 1 W) at 3, 9 and 12 months. " 09/01/2003 - "Fifty COPD patients (age 58.7 +/- 9.1 years, FEV1%pred = 39.3 +/- 17.0%, Baseline Dyspnoea Index (BDI) = 4.9 +/- 2.5, Six Minute Walk Distance (6MWD) = 373 +/- 128 m, Symptoms score = 9.4 +/- 2.5; mean +/- SD) participated in the study. " Order ALL the reference details at left...
3.	Body Weight (Weight, Body) 12/01/1996 - "For Junior Infantry Soldier Recruits, there was no significant change in body weight but a significant reduction in pred VO2max (-2.4%) and a trend towards increased isometric muscular strength. " 05/01/2009 - "Alternatively, a dosage of 2 mg/kg body weight per day (W PRED) can be used. " 01/01/2009 - "PRED did not induce any significant change in body weight, body composition or food intake. " 01/01/2003 - "RESULTS: Body weights in the PRED group were decreased by 26% as compared with body weights in the CONT group, and body weights in the COMBO group were decreased by 11% as compared with body weights in the CONT group. " 11/01/2002 - "Furthermore, female patients may derive further benefits of Pred withdrawal resulting from the concomitant loss of body weight and abdominal fat." Order ALL the reference details at left...
4.	Inflammation 01/01/2008 - "Tissue inflammation was significantly attenuated in PRED dogs. " 01/01/1984 - "PRED also diminished degeneration and inflammation. " 11/01/2006 - "The active inflammation was treated topically with Pred Forte and cyclopentolate and resolved without sequelae. " 08/01/2005 - "PURPOSE: This study was conducted to evaluate the efficacy of two topical steroid prednisolone preparations (Econopred Plus 1%, prednisolone acetate 1%: EPP; Pred Fortedagger 1%, prednisolone acetate 1%: PF) in reducing postoperative inflammation in cataract patients. " 07/01/1997 - "Pred inhibited antigen-induced IgE antibody production, airway inflammation and AHR to acetylcholine. " Order ALL the reference details at left...
5.	Cataract (Cataracts) 08/01/2005 - "PURPOSE: This study was conducted to evaluate the efficacy of two topical steroid prednisolone preparations (Econopred Plus 1%, prednisolone acetate 1%: EPP; Pred Fortedagger 1%, prednisolone acetate 1%: PF) in reducing postoperative inflammation in cataract patients. " 08/01/2000 - "CONCLUSIONS: Using Acular as a single agent was as effective as the combination of preoperative Ocufen and postoperative Pred Forte in preventing intraoperative miosis and postoperative inflammation in cataract surgery. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Prednisolone (Predate)
2.	Prednisone (Sone)
3.	Dexamethasone (Maxidex)
4.	Methylprednisolone
5.	Budesonide (Pulmicort)
6.	Intravenous Immunoglobulins (IVIG)
7.	prednisolone acetate
8.	Potassium
9.	Nisone
10.	dexamethasone acetate

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Transplantation (Transplant Recipients)
3.	Kidney Transplantation
4.	Homologous Transplantation (Allograft)
5.	Pneumonectomy (Lung Volume Reduction)

Best Treatments:
Research Summary Report
on Asthma

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2978 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>